Pay in 4 interest-free payments of $5.48 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Most patients can self-administer the injection at home after receiving guidance from their provider, making it a convenient option for weight loss
3 Previous randomized control trials of semaglutide in diabetic and non-diabetic populations have suggested that non-diabetic patients lose more weight than diabetic patients when prescribed semaglutide, but those studies do not represent real-world data and did not evaluate doses lower than 2.4 mg
Both drugs contain tirzepatide as the active ingredient, but Mounjaro is approved to treat Type 2 diabetes, while Zepbound is approved for weight loss and obstructive sleep apnea in adults with obesity
It's the first combination of 2 classes of medications, the GIP and GLP-1 receptor agonist which are both incretin hormones that are released after food intake
US$ 24.83
US$ 24.74
/assets/images/provider/photos/2785877.jpeg)
US$ 21.02
US$ 26.15
